PotNetwork is pleased to bring you our Marijuana Stock Weekend from our partner publication Grizzle. Grizzle journalist and Head of Research Scott Willis covers the marijuana stock market in-depth, with over 12 years of institutional investment management experience in analyzing both debt and equity securities. He has held senior investment research roles at Credit Suisse and TD Asset Management. He’s also a Chartered Financial Analyst and has been featured on BNN Bloomberg and CBC. For more of Scott’s writing check out Grizzle - the language of new money.

Bottom Line: The next investing frenzy will be in CBD, THCs non-psychoactive cousin. Grizzle did a deep dive into the CBD market to illuminate the potential along with the three stocks best positioned to play the trend. Ignore this information at your own risk.

Source: Grizzle Estimates

Read more»

Bottom Line: Even though there are some questions around the company’s cost structure and declining patient numbers, nothing in the earnings report changes our view that Aurora is ready for legalization and remains one of the two best-positioned targets, along with Aphria, for a beverage giant who wants to enter the market.

All-In Production Costs per Gram by Producer

Source: SEDA

[GW Pharmaceutical stock rallies in anticipation of commercial sales of EPIDIOLEX following DEA decision]

Read more»

Bottom Line: Ontario looks committed to fostering a free retail market in the province. If the government really wants to prevent big producers from owning more than one store, they can structure the regulations to prevent loopholes. If we assume owning a retail store is profitable, these regulations have now decreased the amount of profit a licensed producer will generate, a negative for cannabis growers.

The proposed cannabis retail store must be located on or within the site set out in the license.

The person and its affiliates, as defined by the regulations, may not between them hold more than one retail store.

[Analyst initiates bullish coverage of Canopy as shareholders approve Constellation deal]

Read more»

Bottom Line: In the first six months of 2018, Germany imported 1,800 kg, 420 kg of which were from Canopy Growth. Tilray on the other hand likely provided less than 5 percent of cannabis oil exported to Germany according to financial filings.

Canopy makes $13.62 per gram in Germany compared to $7.20 per gram in Canada. Canada supplies 60 percent of Cannabis consumed in Germany.

[Planet 13 Holdings lists on the OTCQB in advance of their superstore launch in Las Vegas]

Read more»

Bottom Line: Aurora's first massive greenhouse, Aurora Sky, is now 50 percent over budget and six months delayed from the original construction schedule provided by the company. This news from Aurora should remind investors that it is in their best interest to build a margin of safety into production and return expectations for licensed producer stocks. This is a brand new industry, and the best operators have not yet been determined. Production and cost guidance from management should be taken as a best-case scenario.

Source: Aurora Cannabis

Read more»

Bottom Line: Even if a new US farm bill takes hemp off a list of controlled substances, it will still take 1-2 years for state-by-state regulations to be decided. In Washington, for example, manufacturing hemp oil, aka CBD oil, is forbidden, demonstrating there are still challenges hemp farmers have to face before they can expand at scale. US hemp acreage is exploding even in the face of strict regulations.

Hemp Acreage Planted by Region

Read more»

Global marijuana stocks took a breather this week and were down 5 percent for the week. News out of Ontario that only one store would be allowed per licensed producer likely contributed to the stock price weakness. The group as a whole is still up 70 percent since the Constellation investment in Canopy Growth was announced last month.

There is a significant M&A premium built into most of the large-cap stocks as investors expect large corporations to enter the market through licensed producer buyouts. If these deals don't occur in the next few months, stocks could retrace recent highs.

Market Outlook

The Canopy Constellation deal gave the market some new momentum starting in August which should carry stocks higher at least through the end of the year. Until we have 3 to 6 months of data from the legal market in Canada, investor enthusiasm should continue to push cannabis stocks higher.

Once the Canadian market opens, we expect retail and wholesale price compression from a legal oversupply. Falling cannabis prices will pressure producer stocks in the second half of 2019.

Source: New Cannabis Ventures

Read more»

United States

Pennsylvania Introduces Legislation to Legalize Recreational Marijuana

Marijuana Products In California Aren’t Making the Grade

Marijuana Plants Officially on Sale in Oklahoma

Canada

Shoppers Drug Mart to Provide Medical Marijuana, Parent Company Eyeing Recreational Sales

Canadian Police Preparing for Shift to Marijuana Legalization

Study Reveals Ideal Pricing Of Cannabis in a Legal Market

International

Israel’s Former Prime Minister Enters the Cannabis Industry

Malaysia Considers Legalizing Medicinal Cannabis in Reaction to Protests